Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review

ABSTRACT Background In T4a laryngeal cancer with thyroid cartilage invasion, no optimal frontline treatment has yet been defined in controlled trials. Methods We reviewed data from 89 patients with T4a laryngeal cancer featuring thyroid cartilage invasion who were treated initially with either total...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2016-08, Vol.38 (8), p.1271-1277
Hauptverfasser: Choi, Yoon Seok, Park, Sang Gon, Song, Eun-Kee, Cho, Sang-Hee, Park, Moo-Rim, Park, Keon Uk, Lee, Ki-Hyeong, Song, Ik-Chan, Lee, Hyo Jin, Jo, Deog-Yeon, Kim, Samyong, Yun, Hwan-Jung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Background In T4a laryngeal cancer with thyroid cartilage invasion, no optimal frontline treatment has yet been defined in controlled trials. Methods We reviewed data from 89 patients with T4a laryngeal cancer featuring thyroid cartilage invasion who were treated initially with either total laryngectomy (n = 53) or a larynx‐preservation strategy (n = 36). Results The median progression‐free survival (PFS) of the total laryngectomy group had not been attained at the time of analysis and was thus significantly longer than that of the larynx‐preservation group (8.7 months). The median overall survival (OS) of patients who underwent total laryngectomy was 87.2 months, significantly longer than that of the larynx‐preservation group (31.3 months). The survival benefit of primary surgery compared to a larynx‐preservation strategy was more striking in patients of lower N classifications. Conclusion Total laryngectomy may be a better therapeutic option to treat T4a laryngeal cancer featuring thyroid cartilage invasion, especially in patients exhibiting limited nodal involvement (N0/N1). © 2016 Wiley Periodicals, Inc. Head Neck, 2016 © 2016 Wiley Periodicals, Inc. Head Neck 38:1271–1277, 2016
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.24438